Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
New York jury holds drugmaker Teva liable in opioid crisis - ABC News
Teva to Pay California $69 Million in Narcolepsy Drug Settlement | Ctech
Patent Docs: Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2019)
Teva rewards CEO Schultz with $4M equity pay bump after companywide cutbacks | Fierce Pharma
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva CEO Says He's Still Hoping For a Nationwide Opioid Settlement | Barron's
Teva Breaks Out Amid Hopes of Global Opioid Settlement
Where is Kåre Schultz? | Ctech
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva Pharmaceutical sees weaker than expected 2019, shares tumble-Business News , Firstpost
Teva sees 25% of US EpiPen auto-injector market by end 2019 | The Times of Israel
Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
Teva Pharmaceutical | PBS NewsHour
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Teams Up With TAU, Weizmann Institute For Early-Stage Drug Research
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire